Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage: Results of a multicentre case-control study

Thrombosis and Haemostasis

Volumn 93, Issue 5, 2005, Pages 867-871

  Krause, Manuela ^a   Sonntag, Barbara ^b   Klamroth, Robert ^c   Heinecke, Achim ^b   Scholz, Carola ^b   Langer, Claus ^b   Scharrer, Inge ^a   Greb, Robert R ^b   von Eckardstein, Arnold ^d   Nowak Göttl, Ulrike ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Lipoprotein (a); Recurrent miscarriage

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; CARDIOLIPIN ANTIBODY; LIPOPROTEIN A; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; RECURRENT ABORTION; RISK FACTOR; SMOKING; THROMBOGENICITY; THROMBOSIS;

ABORTION, HABITUAL; ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTITHROMBINS; BODY MASS INDEX; CASE-CONTROL STUDIES; FACTOR V; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; LIPOPROTEIN(A); LOGISTIC MODELS; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD+); MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN; RISK FACTORS; THROMBOSIS;

EID: 21044447515     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-08-0519     Document Type: Article

References (41)

1. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996;87:3531-44.
2. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.
3. Schaefer EJ, Lamon-Fava S, Jenner JL, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA 1994; 271: 999-1003.
4. Nagayama M, Shinohara Y, Nagayama T. Lipoprotein(a) and ischemic cerebrovascular disease in young adults. Stroke 1994; 25: 74-8.
5. Ariyo AA, Thach C, Tracy R. Lp(a) lipoprotein, vascular disease and mortality in the elderly. N Engl J Med 2003; 349: 2108-15.
6. Nowak-Göttl U, Junker R, Hartmeier M, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100: 743-8.
7. von Depka M, Nowak-Göttl U, Eisert R, et al. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 2000; 96: 3364-8.
8. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904-10.
9. Hajjar KA, Gavish D, Breslow JL, et al. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303-5.
10. Brenner B, Sari G, Weiner Z, et al. Thrombophilic polymorphisms are common in women with foetal loss without apparent cause. Thromb Haemost 1999; 82: 6-9.
11. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340:9-13.
12. Berg K, Roald B, Sande H. High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation. Clin Gen 1994; 46: 52-6.
13. Kuttell WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999; 71: 1048-53.
14. Martinelli I, Taioli E, Cetin I, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000; 343: 1015-8.
15. Sarig G, Younis JS, Hoffman I, et al. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril. 2002; 77: 342-7.
16. Hohlagschwandtner M, Unfried G, Heinze G, et al. Combined thrombophilic polymorphisms in women with idiopathic recurrent miscarriage. Fertil Steril 2003; 79: 1141-8.
17. Rey E, Kahn SR, David M, et al. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361: 901-8.
18. Clifford K, Rai R, Watson H, et al. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9: 1328-32.
19. Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database Syst Rev 2003: CD003580.
20. Stirrat GM. Recurrent spontaneous abortion. In: Coulam CB, Faulk WP, McIntrue JA, eds. Immunological Obstetrics. New York: W.W. Norton & Company: 1992: 357-76.
21. Bertina RM, Koelemann BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 396: 64-7.
22. Poort SR, Rosendaal F, Reitsma PH, et al. A common generic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
23. Froost P, Bloom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
24. Falk G, Almquist A, Nordenhem A, et al. Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis 1995; 9: 170-4.
25. Junker R, Koch HG, Auberger K, et al. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999; 19: 2568-72.
26. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley 1989, pp 187-215.
27. Van Pampus MG, Koopman MM, Wolf H, et al. Lipoprotein (a) concentrations in women with a history of severe preeclampsia. A case-control study. Thromb Haemost 1999; 82: 10-3
28. Von Kries R, Junker R, Oberle D, et al. Foetal growth restriction in children with prothrombotic risk factors. Thromb Haemost 2001; 86: 1012-6.
29. Von Eckardstein A, Schulte H, Cullen P, et al. Lipoprotein (a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Col Cardiol 2001; 37: 434-9.
30. Danesh J, Collins R, Peto R. Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000; 102: 1082-5.
31. Sträter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors of recurrent stroke during childhood - a 5-year follow-up study. Lancet 2002; 360: 1540-5.
32. Kronenberg F, Lingenhel A, Lhotta K, et al. The apolipoprotein (a) size polymorphism is associated with nephrotic syndrome. Kidney Int 2004; 65: 606-12.
33. Seriolo B, Accardo S, Fasciolo D, et al. Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis. Clin Exp Rheumatol 1996; 14: 593-9.
34. Harpel PC, Gordon BR, Parker TS. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci USA 1989; 86: 3847-51.
35. Scanu AM, Fless GM. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest 1990; 85: 1709-15.
36. Hancock MA, Boffa MB, Marcovina SM, et al. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces. J Biol Chem 2003; 287: 23260-9.
37. Utermann G, Duba C, Menzel HJ. Genetics of the quantitative Lp(a) lipoprotein trait. II. Inheritance of Lp(a) glycoprotein phenotypes. Hum Genet 1988; 78: 47-50.
38. Boerwinkle E, Leffert CC, Lin J, et al. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. J Clin Invest 1992; 90: 52-60.
39. Glueck CJ, Kupferminc MJ, Fontaine RN, et al. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001; 97: 44-8.
40. Gris JC, Mercier E, Quere, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004; 103: 3695-9.
41. Kovalevsky G, Gracia CR, Berlin JA, et al. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. A meta-analysis. Arch Internal Med 2004; 164: 558-63.